NCT05931536

Brief Summary

This study aims to investigate the relationship between diet and the microbiota-gut-brain axis.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
350

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 14, 2022

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

June 12, 2023

Completed
23 days until next milestone

First Posted

Study publicly available on registry

July 5, 2023

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 14, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 14, 2025

Completed
Last Updated

September 24, 2024

Status Verified

September 1, 2024

Enrollment Period

3 years

First QC Date

June 12, 2023

Last Update Submit

September 20, 2024

Conditions

Keywords

Microbiota-gut-brain axisDietCognitionStressDietary fibre

Outcome Measures

Primary Outcomes (5)

  • Trait stress/mood: self-report

    Self-report questionnaires

    Compared at baseline

  • Trait stress/mood: hypothalamic-pituitary-adrenal axis activity

    Cortisol from saliva samples

    Compared at baseline

  • Responses to acute stress: self-report

    Self-report questionnaires

    Compared at baseline

  • Responses to acute stress: hypothalamic-pituitary-adrenal axis activity

    Cortisol from saliva samples

    Compared at baseline

  • Responses to acute stress: sympathetic-adrenal-medullary pathway activity

    Galvanic skin response taken from the skin on the hand

    Compared at baseline

Secondary Outcomes (12)

  • Cognitive performance: working memory

    Compared at baseline

  • Cognitive performance: episodic memory

    Compared at baseline

  • Cognitive performance: decision making

    Compared at baseline

  • Cognitive performance: emotional inhibition

    Compared at baseline

  • Cognitive performance: sustained attention

    Compared at baseline

  • +7 more secondary outcomes

Study Arms (3)

Low fibre consumers

Healthy adults consuming less than or equal to 18 grams of fibre per day.

Other: Dietary fibre

Moderate fibre consumers

Healthy adults consuming between 18.1-24.9 grams of fibre per day.

Other: Dietary fibre

High fibre consumers

Healthy adults consuming greater than or equal to 25 grams of fibre per day.

Other: Dietary fibre

Interventions

Habitual dietary consumption from a variety of foods will be assessed using 7-day food logs entered by the participant and assessed for accuracy by a dietitian.

High fibre consumersLow fibre consumersModerate fibre consumers

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Healthy adult volunteers consuming varying amounts of dietary fibre.

You may qualify if:

  • Be able to give written informed consent.
  • Be between 18 and 50 years of age.
  • Have a body mass index (BMI) between 18.5-29.9 Kg/m2.
  • Be in generally good health as determined by the investigator.

You may not qualify if:

  • Are less than 18 and greater than 50 years of age.
  • Have a BMI below 18.5 or above 29.9 Kg/m2.
  • Have a significant acute or chronic coexisting illness \[cardiovascular, gastrointestinal (GI) \[to include functional GI disorders, inflammatory bowel disease, coeliac disease, lactose intolerance, food allergies\], immunological, psychiatric \[to include formal or as determined by MINI Psychiatric interview, diagnosis of current major depression, anxiety disorder, bipolar spectrum disorder, schizophrenia, other DSM-IV Axis I disorder\], neurodevelopmental disorders, immunological, metabolic disorders \[to include type I or II diabetes\], or any condition which contraindicates, in the investigators judgement, entry to the study.
  • Have a condition or taking a medication that the investigator believes would interfere with the objectives of the study, pose a safety risk, or confound the interpretation of the study results; all psychoactive medications \[to include anxiolytics, antipsychotics, antidepressants, anticonvulsants, centrally acting corticosteroids, and opioid pain relievers), laxatives, enemas, antibiotics, anti-coagulants, over-the counter non-steroidal anti-inflammatories (NSAIDS). Subjects should have a wash-out period of 4 weeks.
  • Current prebiotic or probiotic supplement use (a wash-out period of 4 weeks after cessation will allow entry to the study).
  • Females who are peri-menopausal, menopausal or post-menopausal.
  • Females who are pregnant or planning a pregnancy, or lactating.
  • Participants who are not fluent in English.
  • Are colour blind.
  • Have dyslexia or dyscalculia.
  • Are a current habitual daily smoker.
  • Individuals who, in the opinion of the investigator, are considered to be poor attendees or unlikely for any reason to be able to comply with the trial.
  • Subjects receiving treatment involving experimental drugs. If the subject has been in a recent experimental trial, these must have been completed not less than 30 days prior to this study.
  • Have a malignant disease or any concomitant end-stage organ disease.
  • Have completed a study in our laboratory in the past 4 years.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

APC Microbiome Ireland

Cork, T12YT20, Ireland

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Blood, saliva, urine, and stool

MeSH Terms

Interventions

Dietary Fiber

Intervention Hierarchy (Ancestors)

Dietary CarbohydratesCarbohydratesFoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • John F Cryan, PhD

    APC Microbiome Irealnd

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Elizabeth Schneider, PhD

CONTACT

Revathy Munuswamy, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 12, 2023

First Posted

July 5, 2023

Study Start

July 14, 2022

Primary Completion

July 14, 2025

Study Completion

July 14, 2025

Last Updated

September 24, 2024

Record last verified: 2024-09

Locations